Xtant Medical Holdings, Inc. (XTNT): Revenue
$133.93M
Year ended 2025-12-31
$109.53M
Trailing 12 months to 2026-06-30
+32.2%
3-year compound annual growth
+20.2%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $133.93M | +14.2% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $117.27M | +28.4% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $91.30M | +57.5% | 2025-03-06, From 2023-01-01 |
| 2022-12-31 | $57.97M | +4.9% | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | $55.26M | +3.6% | 2023-03-07, From 2021-01-01 |
| 2020-12-31 | $53.34M | -17.5% | 2022-03-08, From 2020-01-01 |
| 2019-12-31 | $64.68M | -10.4% | 2021-02-24, From 2019-01-01 |
| 2018-12-31 | $72.20M | -12.6% | 2020-03-05, From 2018-01-01 |
| 2017-12-31 | $82.61M | n/a | 2019-04-01, From 2017-01-01 |
| No annual figure between 2011-12-31 and 2017-12-31. | |||
| 2011-12-31 | $30.15M | +95.6% | 2012-03-29, From 2011-01-01 |
| 2010-12-31 | $15.42M | n/a | 2012-03-29, From 2010-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | 2025-12-31 | $133.93M | +14.2% |
| InfuSystem Holdings, Inc (INFU) | 2025-12-31 | $143.44M | +6.4% |
| Neuronetics, Inc. (STIM) | 2025-12-31 | $149.16M | +99.2% |
| Orasure Technologies Inc (OSUR) | 2025-12-31 | $115.02M | -38.1% |
| Anika Therapeutics, Inc. (ANIK) | 2025-12-31 | $112.82M | -5.9% |
| Heartflow, Inc. (HTFL) | 2025-12-31 | $176.03M | +39.9% |
| Beta Bionics, Inc. (BBNX) | 2025-12-31 | $100.25M | +53.9% |
| NeuroPace Inc (NPCE) | 2025-12-31 | $99.99M | +25.1% |
| Kestra Medical Technologies, Ltd. (KMTS) | 2026-04-30 | $95.13M | +59.0% |
Compare XTNT, INFU, STIM, OSUR side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗